The regenerative power and concentrated benefits of combining the latest developments in cell and cell-free regenerative therapy is now available to treat neurological conditions. The heavy personal and social taxing of facing diseases that not only fade the mind, but are also becoming an epidemic, can now be relieved with a treatment that restores brain and systemic function.
Alzheimer’s Disease is the most common cause of adult dementia and one of the leading causes of death in the United States. This mentally, physically and emotionally draining disease has increased its death toll by more than 80% in the last 20 years. Parkinson’s Disease affects over 5 million people worldwide and it is estimated 1 in 50 seniors over the age of 80 will develop this condition. It is worth noting that not only adults struggle with neurological disorders. Today, 1 in 60 children are diagnosed with Autism. This adds to a 300% increase in Autism cases since the year 2000.
These neurological conditions share more than a noticeable increase rate. They are progressive, can only be diagnosed with signs and symptoms and, until now, there was no known way to prevent them. They also share similar effects in the brain. In Alzheimer’s, amyloid plaques and protein tangles block brain cell communication. In Parkinson’s, movement neurotransmitter cells die and an accumulation of proteins impairs neuronal signals. Autism is consequence of abnormal brain development where imbalanced brain structuring during childhood limits proper brain function. In these neurological conditions, atypical brain cell communication and poor brain networking lead to cognitive, motor and social deficits.
Mesenchymal stem cell exosomes are known to follow neuro-inflammatory pathways to start their restorative process. Their growth factors promote neuronal survivability by stimulating neuron and support cell proliferation. Their bio-molecules reduce inflammation and harmful immune responses. MSCs exosomes effectively counteract the pathological outcomes of neurodegenerative diseases.
PRMEDICA’s Neurological Therapies combine the neuroprotective mechanisms of exosomes with the regenerative, anti-inflammatory and immunomodulatory properties of stem cells. Our neurological treatments are designed to address the neurological, physical and metabolic therapeutic challenges of these conditions.